Home Newsfeeds Novartis Warns U.S. Plan To Curb Drug Prices Could Hit Key Research

News

Novartis Warns U.S. Plan To Curb Drug Prices Could Hit Key Research

– Reuters

byBenzinga Newsdesk

January 20, 2023

1 minute read

– Reuters

SOBRsafe Reports Full Year 2022 Results; The Company’s Cash Position Improved To $8.6M

By Happy Mohamed

March 31, 3:53 PM

Full Year 2022 Financial Results The Company's cash position improved to $8.6 million, an 872% increase from $882,268 in the prior year period. The increase was the result of two

SOBR

Credit Suisse Downgrades Paysafe to Underperform

By Benzinga Newsdesk

August 11, 5:07 AM

Credit Suisse analyst Timothy Chiodo downgrades Paysafe (NYSE:PSFE) from Neutral to Underperform.

PSFE

“Synthetic Biologics has received a Notice of Allowance for its US patent application 17/314,583 titled ‘E. COLI-BASED PRODUCTION OF BETA-LACTAMASE (FOR MICROBIOME-PROTECTING THERAPY)’. Recent reverse split.” – PatentGrants

By Benzinga Newsdesk

September 13, 10:54 AM

https://twitter.com/PatentGrants/status/1569700636505296901 https://patentcenter.uspto.gov/#!/applications/17314583/ifw/docs

SYN

Alpine Immune Sciences Presents New Translational Data On Acazicolcept In Systemic Lupus Erythematosus At American College Of Rheumatology Convergence 2023

By Benzinga Newsdesk

November 13, 10:14 AM

-- Phase 2 Study in SLE (Synergy) Ongoing --Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases,

ALPN

Novartis Warns U.S. Plan To Curb Drug Prices Could Hit Key Research

Related Posts

SOBRsafe Reports Full Year 2022 Results; The Company’s Cash Position Improved To $8.6M

Credit Suisse Downgrades Paysafe to Underperform

“Synthetic Biologics has received a Notice of Allowance for its US patent application 17/314,583 titled ‘E. COLI-BASED PRODUCTION OF BETA-LACTAMASE (FOR MICROBIOME-PROTECTING THERAPY)’. Recent reverse split.” – PatentGrants

Alpine Immune Sciences Presents New Translational Data On Acazicolcept In Systemic Lupus Erythematosus At American College Of Rheumatology Convergence 2023